Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rHIgM22
rHIgM22
Acorda cautiously steps forward with a drug to spur remyelination in MS
Fierce Biotech
Mon, 02/2/15 - 07:52 am
Acorda Therapeutics
MS
multiple sclerosis
remylination
rHIgM22